Final analysis of a phase II trial of neoadjuvant chemoimmunotherapy for locoregionally advanced head and neck squamous cell carcinoma. Zhao X, Zhou Y, Peng G, Wen L, et al. Oral Oncol 2024;156:106918.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhao X, Zhou Y, Peng G, Wen L, et al. Final analysis of a phase II trial of neoadjuvant chemoimmunotherapy for locoregionally advanced head and neck squamous cell carcinoma. Oral Oncol 2024;156:106918.
PMID: 38943870